Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
SCHILLER AG
AMPRONIX

Innovative Mammography Technology Increases Detection Rate

By Medimaging International staff writers
Posted on 18 Feb 2014
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the right craniocaudal image (Photo courtesy of Radiological Society of North America).
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the right craniocaudal image (Photo courtesy of Radiological Society of North America).
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the right mediolateral oblique image (Photo courtesy of Radiological Society of North America).
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the right mediolateral oblique image (Photo courtesy of Radiological Society of North America).
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants. The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the zoomed in craniocaudal image of the lesion (Photo courtesy of Radiological Society of North America).
Image: Two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants. The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the zoomed in craniocaudal image of the lesion (Photo courtesy of Radiological Society of North America).
A new photon-counting technique used with digital mammography screening has been shown to provide high diagnostic accuracy.

The study’s findings were published online February 2014 in the journal Radiology. While mammography screening has shifted to digital technology, a range of computed radiography (CR) and direct radiography (DR) systems have emerged. The photon-counting technique shows promise as a DR application that employs a unique detector to decrease scattered radiation and noise, enabling dose reduction and making it a promising tool for screening. “In population-based mammography screening, dose reducing techniques that don’t compromise outcome parameters are desirable,” said Walter Heindel, MD, from the department of clinical radiology at the University Hospital Muenster (Muenster, Germany).

For the study, Dr. Heindel and colleagues examined data for the study from the mammography-screening program in North Rhine-Westphalia, the most populated state in Germany. They compared the screening effectiveness of a DR photon-counting scan system with those of statewide operating screening units using different digital technologies. During the study period (2009–2010), 13,312 women were examined using the photon-counting system, and 993,822 women were screened with either CR or DR systems alone.

The DR photon-counting scan system had a cancer detection rate of 0.76% for subsequent screening, compared with 0.59% for the other screening units. The recall rate was 5.4% for the photon-counting technology and 3.4% for the other techniques. “The higher cancer detection resulting from the use of the DR photon-counting scan system is due to high detection of both small, invasive cancers and ductal carcinoma in situ,” Dr. Heindel said.

The photon-counting technique had nearly twice the detection rate of other techniques for ductal carcinoma in situ (DCIS), an early, noninvasive form of the disease. It had a higher DCIS detection rate than the statewide units and the conventional DR subgroup. Moreover, the mean average glandular radiation dose of the DR photon-counting scan system was substantially lower than the traditional DR systems with the individually used parameters of the automatic exposure control. The study’s large size distinguishes it from earlier studies that compared the DR photon-counting scan system’s performance with other approaches. “To our knowledge, the study is different from previous ones as we examined the performance of the DR photon-counting scan mammography on a larger database with consideration of multiple parameters of screening,” said study coauthor Stefanie Weigel, MD, from the University Hospital Muenster.

The photon-counting technique also offers lateral dose modulation during the image acquisition, which can help account for differences in breast density. Cancer frequently is more difficult to identify in women with dense breasts. “The innovative photon-counting technique offers further research potential,” Dr. Heindel said. “One future research direction is the application of spectral imaging for quantification of breast glandular tissue, addressing the problem of breast density.”

Related Links:

University Hospital Muenster



RADCAL
SuperSonic Imagine
RTI ELECTRONICS AB

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Ultrasound

view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.